Erratum: Expression of concern: The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells (PLoS ONE (2011) 6: 5 (e19724) DOI: 10.1371/journal.pone.0019724);The interplay between NF-kappab and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Palomer, Xavier ^a   Álvarez Guardia, David ^a   Davidson, Mercy M ^b   Chan, Tung O ^c   Feldman, Arthur M ^c   Vázquez Carrera, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; PYRUVATE DEHYDROGENASE KINASE 4; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR E2F1; E2F1 PROTEIN, HUMAN; GLUCOSE; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CELL CYCLE REGULATION; CELL METABOLISM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENETICS; HEART; IMMUNOPRECIPITATION; INFLAMMATION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GLUCOSE; HEART; HUMANS; IMMUNOPRECIPITATION; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956349485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0216434     Document Type: Erratum

References (33)

1. Bergman MR, Kao RH, McCune SA, Holycross BJ, (1999) Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats. Am J Physiol 277: H543-H550.
2. Turner NA, Mughal RS, Warburton P, O'regan DJ, Ball SG, et al. (2007) Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: Effects of statins and thiazolidinediones. Cardiovasc Res 76: 81-90.
3. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, et al. (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J Mol Biol 375: 637-649.
4. Vara D, Bicknell KA, Coxon CH, Brooks G, (2003) Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem 278: 21388-21394.
5. La Thangue NB, (2003) The yin and yang of E2F-1: balancing life and death. Nat Cell Biol 5: 587-589.
6. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, et al. (1998) Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12: 95-106.
7. Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, et al. (2006) Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 281: 39897-39906.
8. Sugden MC, Holness MJ, (2006) Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem 112: 139-149.
9. Finck BN, Kelly DP, (2007) Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115: 2540-2548.
10. Ventura-Clapier R, Garnier A, Veksler V, (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha}. Cardiovasc Res 79: 208-217.
11. Palomer X, Álvarez-Guardia D, Rodriguez-Calvo R, Coll T, Laguna JC, et al. (2009) TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 81: 703-712.
12. Planavila A, Laguna JC, Vázquez-Carrera M, (2005) Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy. J Biol Chem 280: 17464-17471.
13. Hlaing M, Spitz P, Padmanabhan K, Cabezas B, Barker CS, et al. (2004) E2F-1 regulates the expression of a subset of target genes during skeletal myoblast hypertrophy. J Biol Chem 279: 43625-43633.
14. Hsieh MC, Das D, Sambandam N, Zhang MQ, Nahle Z, (2008) Regulation of the PDK4 Isozyme by the Rb-E2F1 Complex. J Biol Chem 283: 27410-27417.
15. Shaw J, Yurkova N, Zhang T, Gang H, Aguilar F, et al. (2008) Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Proc Natl Acad Sci U S A 105: 20734-20739.
16. Araki K, Kawauchi K, Tanaka N, (2008) IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors. Oncogene 27: 5696-5705.
17. Wells J, Graveel CR, Bartley SM, Madore SJ, Farnham PJ, (2002) The identification of E2F1-specific target genes. Proc Natl Acad Sci U S A 99: 3890-3895.
18. Alvarez-Guardia D, Palomer X, Coll T, Davidson MM, Chan TO, et al. (2010) The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res 87: 449-458.
19. Connaughton S, Chowdhury F, Attia RR, Song S, Zhang Y, et al. (2010) Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol 315: 159-167.
20. Darville MI, Rousseau GG, (1997) E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene. Nucleic Acids Res 25: 2759-2765.
21. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T, (2000) Regulation of E2F1 activity by acetylation. EMBO J 19: 662-671.
22. Tu Z, Prajapati S, Park KJ, Kelly NJ, Yamamoto Y, et al. (2006) IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J Biol Chem 281: 6699-6706.
23. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH, (1999) E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 4: 771-781.
24. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, et al. (2002) E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9: 1017-1029.
25. Chen M, Capps C, Willerson JT, Zoldhelyi P, (2002) E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation 106: 2707-2713.
26. Lim CA, Yao F, Wong JJ, George J, Xu H, et al. (2007) Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell 27: 622-635.
27. Lydell CP, Chan A, Wambolt RB, Sambandam N, Parsons H, et al. (2002) Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res 53: 841-851.
28. Davidson MM, Nesti C, Palenzuela L, Walker WF, Hernandez E, et al. (2005) Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 39: 133-147.
29. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, et al. (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81: 627-635.
30. Li YY, Chen D, Watkins SC, Feldman AM, (2001) Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity. Circulation 104: 2492-2497.
31. Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, et al. (2006) Palmitate-mediated downregulation of peroxisome proliferator receptor γ coactivator 1α (PGC-1α) in skeletal muscle cells involves MEK1/2 and NF-κB activation. Diabetes 55: 2779-2787.
32. Freeman WM, Walker SJ, Vrana KE, (1999) Quantitative RT-PCR: pitfalls and potential. Biotechniques 26: 112-115.
33. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.